For over 20 years biolitec® has been working together closely with leading physicians and medical institutions all over the world to improve minimally invasive laser therapies.
Physicians, who have been using the biolitec® laser therapies for years, are an important part in the company's product developments. A lot of physicians are conducting medical studies and trials in which long-term effects of the biolitec® therapies are analyzed.
Now, we would like to share with you the latest results and invite you to contact us to share experiences and discuss with us.
LIFE for Benign Prostate Hyperplasia
Leonradi, Rosario: "The LEST technique: Treatment of prostatic obstruction preserving antegrade ejaculation in patients with benign prostatic hyperplasia", in: Archivio Italiano Di Urologia E Andrologia 2019, 91(1), 35-42. https://doi.org/10.4081/aiua.2019.1.35
Miyazaki, Hideyo et al: "Early Experiences of Contact Laser Vaporization of the Prostate using the 980 nm High Power Diode Laser for Benign Prostatic Hyperplasia", in: Lower Urinary Tract Symptoms 2017, 10: 242-246. https://doi.org/10.1111/luts.12173
TULA® – Trans Urethral Laser Ablation of Recurring Bladder Tumors
Agrawal, S. et al: "Outpatient Transurethral Laser Ablation for Urothelial Cancer - A safe alternative to TURPT in the era of Covid-19", Poster for 40th Congress of the Société Internationale d'Urologie (SIU) in October 2020 [read]
Hermann G. G. et al: "Outpatient diode laser treatment of intermediate-risk non-invasive bladder tumors without sedation: efficacy, safety and economic analysis", in: Scandinavian Journal of Urology 2018, Vol 52, Issue 3, pages 194-198. https://doi.org/10.1080/21681805.2018.1450782